Parkinson's disease: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Meg Taylor
m (moved Parkinson disease to Parkinson's disease: Move to correct name)
mNo edit summary
 
(One intermediate revision by one other user not shown)
Line 1: Line 1:
{{subpages}}
{{subpages}}
In [[medicine]], '''Parkinson disease (PD)''', also called '''primary Parkinsonism''', '''Paralysis Agitans''', and other names, is a disease affecting movement. "The four primary symptoms of PD are [[tremor]], or trembling in hands, arms, legs, jaw, and face; [[rigidity (neurology)|rigidity]], or stiffness of the limbs and trunk; [[bradykinesia]], or slowness of movement; and [[postural instability]], or impaired balance and coordination".<ref>{{citation
In [[medicine]], '''Parkinson's disease (PD)''', also called '''primary Parkinsonism''', '''Paralysis Agitans''', and other names, is a disease affecting movement. "The four primary symptoms of PD are [[tremor]], or trembling in hands, arms, legs, jaw, and face; [[rigidity (neurology)|rigidity]], or stiffness of the limbs and trunk; [[bradykinesia]], or slowness of movement; and [[postural instability]], or impaired balance and coordination".<ref>{{citation
  | url = http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm
  | url = http://www.ninds.nih.gov/disorders/parkinsons_disease/parkinsons_disease.htm
  | title = NINDS Parkinson's Disease Information Page
  | title = NINDS Parkinson's Disease Information Page
Line 11: Line 11:
Common to the types is the death or inability of cells in the substantia nigra to produce the [[neurotransmitter]], [[dopamine]]; dopamine replacement and modulation is at the center of medical treatment.
Common to the types is the death or inability of cells in the substantia nigra to produce the [[neurotransmitter]], [[dopamine]]; dopamine replacement and modulation is at the center of medical treatment.
Some forms of Parkinson disease are inherited<ref>{{OMIM|168600}}</ref> via genes such as [[leucine-rich repeat kinase 2]] (LRRK2)<ref>{{OMIM|609007}}</ref>.
Some forms of Parkinson disease are inherited<ref>{{OMIM|168600}}</ref> via genes such as [[leucine-rich repeat kinase 2]] (LRRK2)<ref>{{OMIM|609007}}</ref>.


==References==
==References==
{{reflist|2}}
{{reflist|2}}[[Category:Suggestion Bot Tag]]

Latest revision as of 12:01, 1 October 2024

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
This editable Main Article is under development and subject to a disclaimer.

In medicine, Parkinson's disease (PD), also called primary Parkinsonism, Paralysis Agitans, and other names, is a disease affecting movement. "The four primary symptoms of PD are tremor, or trembling in hands, arms, legs, jaw, and face; rigidity, or stiffness of the limbs and trunk; bradykinesia, or slowness of movement; and postural instability, or impaired balance and coordination".[1] In other words, Parkinson's disease is a Parkinsonian disorders, but not all Parkinsonian disorders are true Parkinson's disease.

Formally, it is progressive, degenerative neurologic disease characterized by a tremor that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. Lewy bodies are present in the substantia nigra and locus coeruleus but may also be found the related diffuse Lewy body disease characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)[2] More specifically, [3]

Etiology

Common to the types is the death or inability of cells in the substantia nigra to produce the neurotransmitter, dopamine; dopamine replacement and modulation is at the center of medical treatment. Some forms of Parkinson disease are inherited[4] via genes such as leucine-rich repeat kinase 2 (LRRK2)[5].

References

  1. NINDS Parkinson's Disease Information Page, National Institute of Neurological Diseases and Stroke
  2. Anonymous (2024), Parkinson's disease (English). Medical Subject Headings. U.S. National Library of Medicine.
  3. Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 168600. World Wide Web URL: http://omim.org/.
  4. Online Mendelian Inheritance in Man, OMIM®. Johns Hopkins University, Baltimore, MD. MIM Number: 609007. World Wide Web URL: http://omim.org/.